Environmental and chemical toxicities: Pathology review

Last updated: November 01, 2022

Environmental and chemical toxicities: Pathology review

before placement

before placement

Acyanotic congenital heart defects: Pathology review
Cyanotic congenital heart defects: Pathology review
Atherosclerosis and arteriosclerosis: Pathology review
Coronary artery disease: Pathology review
Peripheral artery disease: Pathology review
Valvular heart disease: Pathology review
Cardiomyopathies: Pathology review
Heart failure: Pathology review
Supraventricular arrhythmias: Pathology review
Ventricular arrhythmias: Pathology review
Heart blocks: Pathology review
Aortic dissections and aneurysms: Pathology review
Pericardial disease: Pathology review
Endocarditis: Pathology review
Hypertension: Pathology review
Shock: Pathology review
Vasculitis: Pathology review
Cardiac and vascular tumors: Pathology review
Dyslipidemias: Pathology review
Adrenal insufficiency: Pathology review
Adrenal masses: Pathology review
Hyperthyroidism: Pathology review
Hypothyroidism: Pathology review
Thyroid nodules and thyroid cancer: Pathology review
Parathyroid disorders and calcium imbalance: Pathology review
Diabetes mellitus: Pathology review
Cushing syndrome and Cushing disease: Pathology review
Pituitary tumors: Pathology review
Hypopituitarism: Pathology review
Diabetes insipidus and SIADH: Pathology review
Multiple endocrine neoplasia: Pathology review
Congenital gastrointestinal disorders: Pathology review
Esophageal disorders: Pathology review
GERD, peptic ulcers, gastritis, and stomach cancer: Pathology review
Inflammatory bowel disease: Pathology review
Malabsorption syndromes: Pathology review
Diverticular disease: Pathology review
Appendicitis: Pathology review
Gastrointestinal bleeding: Pathology review
Colorectal polyps and cancer: Pathology review
Pancreatitis: Pathology review
Gallbladder disorders: Pathology review
Jaundice: Pathology review
Viral hepatitis: Pathology review
Cirrhosis: Pathology review
Microcytic anemia: Pathology review
Non-hemolytic normocytic anemia: Pathology review
Intrinsic hemolytic normocytic anemia: Pathology review
Extrinsic hemolytic normocytic anemia: Pathology review
Macrocytic anemia: Pathology review
Heme synthesis disorders: Pathology review
Coagulation disorders: Pathology review
Platelet disorders: Pathology review
Mixed platelet and coagulation disorders: Pathology review
Thrombosis syndromes (hypercoagulability): Pathology review
Lymphomas: Pathology review
Leukemias: Pathology review
Plasma cell disorders: Pathology review
Myeloproliferative disorders: Pathology review
Immunodeficiencies: T-cell and B-cell disorders: Pathology review
Immunodeficiencies: Combined T-cell and B-cell disorders: Pathology review
Immunodeficiencies: Phagocyte and complement dysfunction: Pathology review
Pigmentation skin disorders: Pathology review
Acneiform skin disorders: Pathology review
Papulosquamous and inflammatory skin disorders: Pathology review
Vesiculobullous and desquamating skin disorders: Pathology review
Skin cancer: Pathology review
Back pain: Pathology review
Rheumatoid arthritis and osteoarthritis: Pathology review
Seronegative and septic arthritis: Pathology review
Gout and pseudogout: Pathology review
Systemic lupus erythematosus (SLE): Pathology review
Scleroderma: Pathology review
Sjogren syndrome: Pathology review
Bone disorders: Pathology review
Bone tumors: Pathology review
Myalgias and myositis: Pathology review
Neuromuscular junction disorders: Pathology review
Muscular dystrophies and mitochondrial myopathies: Pathology review
Congenital neurological disorders: Pathology review
Headaches: Pathology review
Seizures: Pathology review
Cerebral vascular disease: Pathology review
Traumatic brain injury: Pathology review
Spinal cord disorders: Pathology review
Dementia: Pathology review
Central nervous system infections: Pathology review
Movement disorders: Pathology review
Demyelinating disorders: Pathology review
Adult brain tumors: Pathology review
Pediatric brain tumors: Pathology review
Neurocutaneous disorders: Pathology review
Congenital renal disorders: Pathology review
Renal tubular defects: Pathology review
Renal tubular acidosis: Pathology review
Acid-base disturbances: Pathology review
Electrolyte disturbances: Pathology review
Renal failure: Pathology review
Nephrotic syndromes: Pathology review
Nephritic syndromes: Pathology review
Urinary incontinence: Pathology review
Urinary tract infections: Pathology review
Kidney stones: Pathology review
Renal and urinary tract masses: Pathology review
Disorders of sex chromosomes: Pathology review
Prostate disorders and cancer: Pathology review
Testicular tumors: Pathology review
Uterine disorders: Pathology review
Ovarian cysts and tumors: Pathology review
Cervical cancer: Pathology review
Vaginal and vulvar disorders: Pathology review
Benign breast conditions: Pathology review
Breast cancer: Pathology review
Complications during pregnancy: Pathology review
Congenital TORCH infections: Pathology review
Choanal atresia
Laryngomalacia
Allergic rhinitis
Nasal polyps
Upper respiratory tract infection
Sinusitis
Laryngitis
Retropharyngeal and peritonsillar abscesses
Bacterial epiglottitis
Nasopharyngeal carcinoma
Respiratory distress syndrome: Pathology review
Cystic fibrosis: Pathology review
Pneumonia: Pathology review
Tuberculosis: Pathology review
Deep vein thrombosis and pulmonary embolism: Pathology review
Pleural effusion, pneumothorax, hemothorax and atelectasis: Pathology review
Obstructive lung diseases: Pathology review
Restrictive lung diseases: Pathology review
Apnea, hypoventilation and pulmonary hypertension: Pathology review
Lung cancer and mesothelioma: Pathology review
Coronary artery disease: Clinical
Heart failure: Clinical
Syncope: Clinical
Pericardial disease: Clinical
Valvular heart disease: Clinical
Infective endocarditis: Clinical
Cardiomyopathies: Clinical
Hypertension: Clinical
Hypercholesterolemia: Clinical
Diabetes mellitus: Clinical
Hyperthyroidism: Clinical
Parathyroid conditions and calcium imbalance: Clinical
Hypothyroidism and thyroiditis: Clinical
Thyroid nodules and thyroid cancer: Clinical
Pituitary adenomas and pituitary hyperfunction: Clinical
Hypopituitarism: Clinical
Cushing syndrome: Clinical
Adrenal insufficiency: Clinical
Adrenal masses and tumors: Clinical
MEN syndromes: Clinical
Esophageal disorders: Clinical
Esophagitis: Clinical
Gastroesophageal reflux disease (GERD): Clinical
Peptic ulcers and stomach cancer: Clinical
Gastroparesis: Clinical
Diarrhea: Clinical
Malabsorption: Clinical
Inflammatory bowel disease: Clinical
Colorectal cancer: Clinical
Diverticular disease: Clinical
Anal conditions: Clinical
Gastrointestinal bleeding: Clinical
Gallbladder disorders: Clinical
Pancreatitis: Clinical
Jaundice: Clinical
Viral hepatitis: Clinical
Cirrhosis: Clinical
Immunodeficiencies: Clinical
Fever of unknown origin: Clinical
Fat-soluble vitamin deficiency and toxicity: Pathology review
Water-soluble vitamin deficiency and toxicity: B1-B7: Pathology review
Zinc deficiency and protein-energy malnutrition: Pathology review
Anemia: Clinical
Leukemia: Clinical
Thrombocytopenia: Clinical
Lymphoma: Clinical
Bleeding disorders: Clinical
Myeloproliferative neoplasms: Clinical
Thrombophilia: Clinical
Plasma cell disorders: Clinical
Blood products and transfusion: Clinical
Pneumonia: Clinical
Urinary tract infections: Clinical
Meningitis, encephalitis and brain abscesses: Clinical
Bites and stings: Clinical
Hypernatremia: Clinical
Hyponatremia: Clinical
Hyperkalemia: Clinical
Hypokalemia: Clinical
Metabolic and respiratory acidosis: Clinical
Metabolic and respiratory alkalosis: Clinical
Toxidromes: Clinical
Medication overdoses and toxicities: Pathology review
Environmental and chemical toxicities: Pathology review
Acute kidney injury: Clinical
Chronic kidney disease: Clinical
Nephritic and nephrotic syndromes: Clinical
Asthma: Clinical
Chronic obstructive pulmonary disease (COPD): Clinical
Cystic fibrosis: Clinical
Diffuse parenchymal lung disease: Clinical
Venous thromboembolism: Clinical
Acute respiratory distress syndrome: Clinical
Pleural effusion: Clinical
Pneumothorax: Clinical
Lung cancer: Clinical
Joint pain: Clinical
Rheumatoid arthritis: Clinical
Seronegative arthritis: Clinical
Systemic lupus erythematosus (SLE): Clinical
Sjogren syndrome: Clinical
Inflammatory myopathies: Clinical
Vasculitis: Clinical
Antihistamines for allergies
Glucocorticoids
Sympatholytics: Alpha-2 agonists
Adrenergic antagonists: Presynaptic
Adrenergic antagonists: Alpha blockers
Adrenergic antagonists: Beta blockers
ACE inhibitors, ARBs and direct renin inhibitors
Thiazide and thiazide-like diuretics
Calcium channel blockers
cGMP mediated smooth muscle vasodilators
Class I antiarrhythmics: Sodium channel blockers
Class II antiarrhythmics: Beta blockers
Class III antiarrhythmics: Potassium channel blockers
Class IV antiarrhythmics: Calcium channel blockers and others
Lipid-lowering medications: Statins
Lipid-lowering medications: Fibrates
Miscellaneous lipid-lowering medications
Positive inotropic medications
Loop diuretics
Antiplatelet medications
Hyperthyroidism medications
Hypothyroidism medications
Insulins
Hypoglycemics: Insulin secretagogues
Miscellaneous hypoglycemics
Adrenal hormone synthesis inhibitors
Mineralocorticoids and mineralocorticoid antagonists
Laxatives and cathartics
Antidiarrheals
Acid reducing medications
Anticoagulants: Heparin
Anticoagulants: Warfarin
Anticoagulants: Direct factor inhibitors
Thrombolytics
Hematopoietic medications
Ribonucleotide reductase inhibitors
Topoisomerase inhibitors
Platinum containing medications
Anti-tumor antibiotics
Microtubule inhibitors
DNA alkylating medications
Monoclonal antibodies
Antimetabolites for cancer treatment
Protein synthesis inhibitors: Aminoglycosides
Antimetabolites: Sulfonamides and trimethoprim
Antituberculosis medications
Miscellaneous cell wall synthesis inhibitors
Protein synthesis inhibitors: Tetracyclines
Cell wall synthesis inhibitors: Penicillins
Miscellaneous protein synthesis inhibitors
Cell wall synthesis inhibitors: Cephalosporins
DNA synthesis inhibitors: Metronidazole
DNA synthesis inhibitors: Fluoroquinolones
Integrase and entry inhibitors
Nucleoside reverse transcriptase inhibitors (NRTIs)
Protease inhibitors
Hepatitis medications
Non-nucleoside reverse transcriptase inhibitors (NNRTIs)
Neuraminidase inhibitors
Herpesvirus medications
Azoles
Echinocandins
Miscellaneous antifungal medications
Anthelmintic medications
Antimalarials
Anti-mite and louse medications
Osmotic diuretics
Carbonic anhydrase inhibitors
Potassium sparing diuretics
Bronchodilators: Beta 2-agonists and muscarinic antagonists
Bronchodilators: Leukotriene antagonists and methylxanthines
Acetaminophen (Paracetamol)
Non-steroidal anti-inflammatory drugs
Opioid agonists, mixed agonist-antagonists and partial agonists
Antigout medications
Osteoporosis medications

Transcript

Watch video only

Kristen is a 47 year old female who showed up at the ER due to vomiting and diarrhea. Kristen works as a farmer, and tells you that her symptoms started right after she sprayed her crops with insecticides using her bare hands. On clinical examination, her pupils appear constricted. And a few minutes later, Kristen has a seizure.

Next comes Federico, a 9 year old boy who is brought to the ER by his parents after accidentally consuming a bottle of insecticide. His parents mention that he complained of stomach ache, and had repeated episodes of vomiting and diarrhea. Upon clinical examination, you first notice that Federico's breath has a characteristic garlic-like odor.

Lastly, you see Richard and Lucy, a 60 year old couple that arrived at the ER, both complaining of a dull headache and nausea. They seem confused, but they mention that their symptoms started more or less at the same time, while they were both relaxing next to the fireplace. Upon clinical examination, you realize that their skin looks cherry red, so you decide to run a blood test, which reveals high carboxyhemoglobin levels.

Based on their history and presentation, all cases seem to have some form of environmental and chemical toxicity. Toxicity refers to the extent of poisoning or damage to the body due to exposure to a toxic substance. For your exams, the most high yield toxic substances include acetylcholinesterase inhibitors; methanol and ethylene glycol; heavy metals, including arsenic, iron, lead, and mercury; cyanide and carbon monoxide; as well as methemoglobin, which is an endogenous substance that can become toxic at high levels.

Let’s start with acetylcholinesterase inhibitor poisoning. Okay, normally, acetylcholinesterases are enzymes that break down the neurotransmitter acetylcholine, so that it can’t activate the cholinergic receptors in the peripheral and central nervous system. And there are two types of cholinergic receptors, called muscarinic and nicotinic receptors. Now, acetylcholinesterase inhibitors are substances that can irreversibly inhibit the acetylcholinesterases at the neuromuscular junction. As a result, acetylcholine builds up in the neuromuscular junction, leading to overstimulation of its receptors.

For your exams, the main acetylcholinesterase inhibitors are organophosphates, such as parathion. These are found in certain insecticides, and can be absorbed through the skin, respiratory or gastrointestinal tract. In a test question, think of acetylcholinesterase inhibitors or organophosphate poisoning if they describe a farmer or an agricultural worker that had an accidental cutaneous exposure, inhalation, or ingestion of excessive amounts of insecticides.

Clinical manifestations of acetylcholinesterase inhibitor poisoning include muscarinic symptoms, which can be easily remembered using the mnemonic DUMBBELSS, that stands for diarrhea, urination, miosis, bronchospasm, bradycardia, emesis, lacrimation, sweating, and salivation. Individuals can also present nicotinic symptoms, such as weakness, paralysis, and fasciculations, which are spontaneous involuntary muscle contractions. Additionally, organophosphates can cross the blood brain barrier and cause CNS symptoms, such as lethargy, seizures, respiratory depression, and coma.

Now, treatment of acetylcholinesterase inhibitor poisoning is high yield and relies on giving atropine and pralidoxime. Atropine directly competes with acetylcholine for muscarinic receptors, thus reversing the muscarinic symptoms; and can also cross the blood brain barrier and relieve the CNS symptoms. On the other hand, pralidoxime reactivates the acetylcholinesterases, so that they can break down acetylcholine in the neuromuscular junction. As a result, remember that pralidoxime reverses both muscarinic and nicotinic symptoms. However, it can’t cross the blood brain barrier, so it has no effect on CNS symptoms.

Next up, there’s methanol, which is most commonly found in windshield washer fluid, and poisoning typically occurs via ingestion. Now, methanol is metabolized by the enzyme alcohol dehydrogenase in the liver into formaldehyde and formic acid, which are toxic and can cause serious damage to the eyes, leading to loss of visual acuity or even blindness. So, on eye examination, there’s usually mydriasis or dilated pupils, as well as optic disc hyperemia or swelling. Methanol poisoning can also cause CNS depression, leading to confusion, stupor, and even coma. Other common findings include bradycardia or low heart rate, bradypnea or slow breathing, hypotension or low blood pressure, and hyporeflexia or decreased reflexes.

Now, it’s very important that you remember that a very similar presentation occurs with ethylene glycol ingestion, which is found in automobile antifreeze, engine coolants, and brake fluids. Also ethylene glycol is metabolized by the enzyme alcohol dehydrogenase in the liver, but into glycolic acid, which is toxic to the renal tubules, and oxalic acid, which can precipitate with calcium, forming calcium oxalate crystals in the renal tubules. As a result, a key difference with methanol is that ethylene glycol poisoning usually presents with symptoms of acute renal failure, such as flank pain and oliguria or decreased production of urine, which typically occur 24 to 72 hours after ingestion. Also, since calcium precipitates into crystals, blood levels of calcium may decrease, leading to tetany or involuntary muscle contractions.

In terms of laboratory findings, remember that both methanol and ethylene glycol poisoning can present with metabolic acidosis, meaning that pH levels are below 7.35, bicarbonate is below 22 mEq/L, and pCO2 levels below 35 mm Hg. And this is combined with a high anion gap, meaning that sodium minus chloride plus bicarbonate equals greater than 12 mEq/L. In addition, since both methanol and ethylene glycol are osmotically active, there’s also a high osmolal gap, meaning greater than 10 mOsm/kg, which is calculated as the measured serum osmolality minus the calculated serum osmolality.

Now, for diagnosis, to set methanol and ethylene glycol apart, you need to check their blood levels. Another high yield difference is that, with ethylene glycol poisoning, urine microscopy may show the calcium oxalate crystals, which have a characteristic folded envelope shape; and on a renal biopsy, glomeruli will appear normal, whereas epithelial cells lining the renal tubules will show signs of damage, like ballooning and vacuolar degeneration.

Moving onto treatment, the antidote for both methanol and ethylene glycol intoxication is fomepizole, which blocks alcohol dehydrogenase. If unavailable, ethanol can be used instead. In severe cases, hemodialysis can be done to quickly remove the toxic metabolites from blood.

Another high yield topic is poisoning by heavy metals, including arsenic, iron, lead, and mercury. Let’s start with arsenic, which is most commonly found in certain herbicides and insecticides, as well as contaminated water used for drinking, food preparation, and irrigation of food crops.

For your exams, remember that acute arsenic poisoning can occur if someone accidentally ingested it, and presents with gastrointestinal symptoms, such as abdominal pain, nausea, vomiting, and diarrhea. In addition, a very characteristic finding that you must know is garlic-like breath odor. Now, arsenic can also affect the CNS, causing drowsiness, confusion, and even delirium. Arsenic can also affect the heart, so another high yield manifestation is a prolonged QT interval on ECG, meaning that there’s a delay between heart beats.

On the other hand, chronic arsenic poisoning occurs due to continuous exposure to arsenic. In a clinical vignette, look for an individual who is a vineyard worker. Now, chronic arsenic poisoning can increase the risk for certain tumors, such as lung cancer, liver angiosarcoma, and squamous cell carcinoma of the skin. Another clue examiners love to give are Mees’s lines, which are white lines across the nails due to arsenic deposition over time.

The main treatment for poisoning by heavy metals like arsenic consists of chelating agents. The way these work is by trapping free metal ions and sweeping them away through feces or urine. For arsenic, the chelating agent of choice is succimer for children and dimercaprol for adults.

The next heavy metal is iron. Now, acute iron poisoning can be caused by excessive consumption of iron supplement tablets. This mainly occurs due to incidental ingestion by children, who may think it’s candy. Acute iron poisoning has a high mortality rate, and it’s clinical presentation is divided into five stages.

In the first stage, there are gastrointestinal symptoms, such as nausea, diarrhea, and abdominal pain. More severe cases may also present gastrointestinal bleeding, which may lead to hematemesis or vomiting of blood if it involves the upper gastrointestinal tract, or melena or black and tarry stools if it involves the lower gastrointestinal tract. Ultimately, the bleeding might lead to hypovolemia and shock. In the second stage, the gastrointestinal symptoms resolve and the individual seems to be getting better. But in the third stage, they might develop anion gap metabolic acidosis, which can ultimately result in stage four with multiorgan failure, especially involving the liver, and can be life-threatening. Finally, those who survive may enter the fifth stage, which is characterized by scarring or fibrosis of the gastrointestinal tissue, which can result in bowel obstruction.

The main treatment for acute iron poisoning consists of chelating agents like deferoxamine or deferasirox, as well as gastric lavage to clean out the toxic substances of the stomach.

Now, chronic iron poisoning, also known as iron overload, refers to the accumulation of excess iron over time. The main causes are hereditary hemochromatosis, an autosomal recessive disease where the body absorbs too much iron from food; as well as multiple blood transfusions, mainly in individuals with hematological conditions, such as thalassemia or sickle cell disease.

The chronic accumulation of iron ultimately becomes toxic, most notably to the liver, causing cirrhosis; but also the pancreas, causing diabetes mellitus. In addition, iron can build up in the heart muscle, leading to cardiomyopathy and arrhythmias. Importantly, accumulation of iron in the pituitary glands can affect the release of sex hormones, leading to hypogonadism; this can result in amenorrhea or absence of menstruation in females, and testicular atrophy in males. And finally, if iron gets into the joints, it can cause arthropathy or degenerative joint disease.

Treatment of chronic iron poisoning can involve chelation, but also phlebotomy, in which blood is withdrawn until the iron load is sufficiently decreased, and then it’s replaced with intravenous fluids.

Sources

  1. "Robbins Basic Pathology" Elsevier (2017)
  2. "Harrison's Principles of Internal Medicine, Twentieth Edition (Vol.1 & Vol.2)" McGraw-Hill Education / Medical (2018)